Fundz

Celltrion acquires Gifrer to boost EU presence

May 12, 2026

Acquiring Company

Celltrion

Acquired Company

Gifrer

IncheonFranceManufacturingBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Celltrion Inc. has acquired the entire stake in French health care company Gifrer to expand its presence in the European Union. The deal emphasizes Celltrion's strategy to operate Gifrer independently while maintaining its employee base. The acquisition is expected to significantly contribute to Celltrion's revenue in the coming years. This move aligns with Celltrion's broader goals of growth through mergers and acquisitions.

Who to call at Celltrion, and when

When Celltrion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Celltrion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Celltrion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Celltrion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Celltrion

Location

Incheon, Seoul, South Korea

About

Celltrion is a leading biopharmaceutical company based in Incheon, South Korea that specialises in researching, developing, manufacturing, marketing and sales of innovative therapeutics that improve people's lives worldwide. The company’s solutions include world-class monoclonal antibody biosimilars such as Remsima®, Truxima® and Herzuma®, providing broader patient access globally. Celltrion has also received U.S. FDA and EC approval for several products, enhancing its portfolio in the biopharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Celltrion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sooyoung
Likely contact at this company
••••••••@••••••••

See Sooyoung's verified email →

Jerome(Jaewoong)
Likely contact at this company
••••••••@••••••••

See Jerome(Jaewoong)'s verified email →

Naresh
Likely contact at this company
••••••••@••••••••

See Naresh's verified email →

Claudette
Senior decision-maker at this company
••••••••@••••••••

See Claudette's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Celltrion's next move

Learn about Strategic plan

Frequently asked

Who acquired Gifrer?

Gifrer was acquired by Celltrion, based in Incheon. The deal was reported on May 12, 2026. Celltrion is privately held and operates in Manufacturing.

When did Celltrion acquire Gifrer?

Celltrion's acquisition of Gifrer was reported on May 12, 2026. Celltrion Inc. has acquired the entire stake in French health care company Gifrer to expand its presence in the European Union. The deal emphasizes Celltrion's strategy to operate Gifrer independently while maintaining its employee base. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Gifrer do?

Gifrer is a French health care company founded in 1912, specializing in over-the-counter pharmaceutical products and health supplements. It offers around 140 types of products, including physiological salt solutions and tooth bleaches. It is privately held, and is based in France.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.